AR108806A1 - Solución de dexmedetomidina lista para el uso, premezclada, esterilizable por calor, envasada en un recipiente de plástico flexible - Google Patents
Solución de dexmedetomidina lista para el uso, premezclada, esterilizable por calor, envasada en un recipiente de plástico flexibleInfo
- Publication number
- AR108806A1 AR108806A1 ARP170101673A ARP170101673A AR108806A1 AR 108806 A1 AR108806 A1 AR 108806A1 AR P170101673 A ARP170101673 A AR P170101673A AR P170101673 A ARP170101673 A AR P170101673A AR 108806 A1 AR108806 A1 AR 108806A1
- Authority
- AR
- Argentina
- Prior art keywords
- plastic container
- sterilizable
- packed
- mixed
- heat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/065—Rigid ampoules, e.g. glass ampoules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/067—Flexible ampoules, the contents of which are expelled by squeezing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Reivindicación 1: Una solución de dexmedetomidina estéril, lista para el uso, premezclada, que comprende dexmedetomidina y un azúcar, envasada en un recipiente de plástico sustancialmente libre de DEHP.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/133,922 US9717796B1 (en) | 2016-04-20 | 2016-04-20 | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container |
US15/185,519 US9649296B1 (en) | 2016-04-20 | 2016-06-17 | Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container |
Publications (1)
Publication Number | Publication Date |
---|---|
AR108806A1 true AR108806A1 (es) | 2018-09-26 |
Family
ID=58671210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP170101673A AR108806A1 (es) | 2016-04-20 | 2017-06-16 | Solución de dexmedetomidina lista para el uso, premezclada, esterilizable por calor, envasada en un recipiente de plástico flexible |
Country Status (6)
Country | Link |
---|---|
US (2) | US9717796B1 (es) |
EP (1) | EP3429574A4 (es) |
AR (1) | AR108806A1 (es) |
AU (1) | AU2016403510A1 (es) |
WO (1) | WO2017184188A1 (es) |
ZA (1) | ZA201807466B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4371554A2 (en) | 2016-12-31 | 2024-05-22 | BioXcel Therapeutics, Inc. | Use of sublingual dexmedetomidine for the treatment of agitation |
WO2019164765A1 (en) * | 2018-02-26 | 2019-08-29 | Slayback Pharma Llc | Ready-to-use dexmedetomidine compositions |
CN108553423A (zh) * | 2018-05-16 | 2018-09-21 | 厦门汇承科技有限公司 | 一种水溶性的兽用地美硝唑预混剂及其制备方法 |
US10966990B2 (en) * | 2018-06-20 | 2021-04-06 | InfoRLife SA | Midazolam in flexible bags |
CN114983980A (zh) | 2018-06-27 | 2022-09-02 | 比奥克斯塞尔医疗股份有限公司 | 含右美托咪定的膜制剂及其制造方法 |
US11160791B2 (en) | 2018-11-01 | 2021-11-02 | Medefil, Inc. | Dexmedetomidine injection premix formulation in ready to use (RTU) bags |
BR112022000992A2 (pt) | 2019-07-19 | 2022-06-14 | Arx Llc | Regimes de tratamento de dexmedetomidina não sedantes |
EP4085891A1 (en) | 2021-05-05 | 2022-11-09 | B. Braun Melsungen AG | Dexmedetomidine-solution in a low-density polyethylene container |
US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2101114B (en) | 1981-07-10 | 1985-05-22 | Farmos Group Ltd | Substituted imidazole derivatives and their preparation and use |
FI844786A0 (fi) | 1984-12-04 | 1984-12-04 | Farmos Oy | Terapeutiskt utnyttjbar foerening. |
GB2206880B (en) | 1987-07-16 | 1991-04-24 | Farmos Oy | Optical isomers of an imidazole derivative |
US5344840A (en) | 1988-02-29 | 1994-09-06 | Orion-Yhtyma Oy | 4-substituted imidazole derivatives useful in perioperative care |
US5124157A (en) | 1989-08-18 | 1992-06-23 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
US5217718A (en) | 1989-08-18 | 1993-06-08 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
FI894911A0 (fi) | 1989-10-17 | 1989-10-17 | Farmos Oy | En terapeutiskt vaerdefull foerening. |
US5304569A (en) | 1989-11-13 | 1994-04-19 | Orion-Yhtyma Oy | Compositions and their use in lowering intraocular pressure |
US5139831A (en) * | 1990-03-02 | 1992-08-18 | W. R. Grace & Co.-Conn. | Impact modified medical film with ph control |
GB2281206A (en) | 1993-08-25 | 1995-03-01 | Orion Yhtymae Oy | Use of dexmedetomidine |
US6716867B1 (en) | 1998-04-01 | 2004-04-06 | Orion Corporation | Use of dexmedetomidine for ICU sedation |
US8100890B2 (en) | 2008-10-15 | 2012-01-24 | Bioquiddity, Inc. | Special purpose fluid dispenser with pre-filled reservoir |
WO2011004390A2 (en) | 2009-06-23 | 2011-01-13 | Terumo Penpol Limited | A process for making non dehp pvc compounds suitable for the fabrication of containers for the storage of platelet concentrates and for making flexible devices and tubing for medical applications |
US20130096170A1 (en) * | 2011-10-14 | 2013-04-18 | Hospira, Inc. | Methods of treating pediatric patients using dexmedetomidine |
US8242158B1 (en) * | 2012-01-04 | 2012-08-14 | Hospira, Inc. | Dexmedetomidine premix formulation |
JP5921928B2 (ja) | 2012-03-28 | 2016-05-24 | テルモ株式会社 | 既希釈デクスメデトミジン製剤 |
EP3054932B1 (en) | 2013-10-07 | 2020-12-09 | Teikoku Pharma USA, Inc. | Dexmedetomidine transdermal delivery devices and methods for using the same |
JP2016154598A (ja) | 2015-02-23 | 2016-09-01 | ニプロ株式会社 | デクスメデトミジン注射液を充填したプレフィルドシリンジ |
-
2016
- 2016-04-20 US US15/133,922 patent/US9717796B1/en active Active
- 2016-06-17 US US15/185,519 patent/US9649296B1/en active Active
- 2016-06-28 EP EP16899673.4A patent/EP3429574A4/en not_active Withdrawn
- 2016-06-28 WO PCT/US2016/039776 patent/WO2017184188A1/en active Application Filing
- 2016-06-28 AU AU2016403510A patent/AU2016403510A1/en not_active Abandoned
-
2017
- 2017-06-16 AR ARP170101673A patent/AR108806A1/es unknown
-
2018
- 2018-11-07 ZA ZA2018/07466A patent/ZA201807466B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US9649296B1 (en) | 2017-05-16 |
EP3429574A1 (en) | 2019-01-23 |
WO2017184188A1 (en) | 2017-10-26 |
ZA201807466B (en) | 2020-02-26 |
US9717796B1 (en) | 2017-08-01 |
AU2016403510A1 (en) | 2018-11-15 |
EP3429574A4 (en) | 2019-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR108806A1 (es) | Solución de dexmedetomidina lista para el uso, premezclada, esterilizable por calor, envasada en un recipiente de plástico flexible | |
NI201700011A (es) | 2-(morfolin-4-il)-1,7-naftiridinas. | |
CO2017001994A2 (es) | Compuestos activos hacia bromodominios | |
CL2019000415A1 (es) | Compuestos terapéuticos útiles para el tratamiento profiláctico o terapéuticos de una infección por el virus del vih. | |
NI201700169A (es) | Derivados de sulfamoilarilamida ciclados y uso de los mismos como medicamentos para el tratamiento de la hepatitis b | |
NI201600115A (es) | Derivados de sulfamoilpirrolamida y su uso como medicamentos para el tratamiento de la hepatitis b. | |
SV2017005461A (es) | Benzamidas sustituidas con 1,3-tiazol-2-ilo | |
CL2015001864A1 (es) | Compuestos derivados de espiropirido[1,2-a]pirazina sustituidos, como inhibidores de la integrasa del vih; composicion farmaceutica que los comprende; y su uso para la profilaxis o el tratamiento de una infeccion por vih. | |
SV2016005257A (es) | Benzimidazol-2-aminas como inhibidores de midh1 | |
DOP2017000156A (es) | Derivados de glucagón con estabilidad mejorada | |
CL2016001918A1 (es) | Heteroaril amidas como inhibidores de agregación de proteína | |
CL2016001756A1 (es) | Preparación farmacéutica que comprende 0,001-0,003 pv de 6-4-pirazol-1-ilbencilpiridin-3-ilsulfonilaminometilpiridin-2-ilaminoacetato de isopropilo o una sal del mismo uso para el tratamiento o prevención de glaucoma o hipertensión ocular. | |
AR102658A1 (es) | Composición para el tratamiento de telas | |
AR106025A1 (es) | Formas cristalinas de ácido siálico o una sal o solvato de este | |
CL2019001996A1 (es) | Usos terapéuticos de un polvo de insectos. | |
DOP2017000014A (es) | Métodos para mejorar el rendimiento miocárdico en pacientes con cirugía de fontan que utilizan composiciones de udenafilo | |
CO2020003228A2 (es) | Nuevas combinaciones agroquimicas | |
AR101581A1 (es) | Composición de colutorio | |
CL2015003286A1 (es) | (ciano-dimetil-metil)-(isoxazoles y -[1, 3, 4] tiadiazoles novedosos | |
BR112017014996A2 (pt) | formulações farmacêuticas e recipientes selados | |
CR20160565A (es) | Derivados de naftiridinadiona | |
ECSP16086232A (es) | (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina | |
MX2017006476A (es) | Terapia de combinacion efectiva contra microorganismos, que incluye microorganismos resistentes a farmacos. | |
CL2015001943A1 (es) | Derivados de bencilamina | |
CL2018001157A1 (es) | Formulación de combinación de dosis fija, eflornitina y sulindaco. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |